Journal of Endocrinology and Metabolism, ISSN 1923-2861 print, 1923-287X online, Open Access |
Article copyright, the authors; Journal compilation copyright, J Endocrinol Metab and Elmer Press Inc |
Journal website http://www.jofem.org |
Original Article
Volume 3, Number 1-2, April 2013, pages 7-15
Safety and Tolerability of the Hexadecapeptide AOD9604 in Humans
Tables
Treatment group | IGF-1 changes from baseline | P-value (mmol/L) compared to placebo |
---|---|---|
Placebo | 0.12 (0.56) | |
1 mg AOD9604 | -0.12 (0.58) | 1.00 |
5 mg AOD9604 | -0.18 (0.55) | 0.99 |
10 mg AOD9604 | 0.41 (0.52) | 0.99 |
20 mg AOD9604 | 1.28 (0.53) | 0.38 |
30 mg AOD9604 | 0.63 (0.59) | 0.95 |
Placebo (n =125) | AOD9604 0.25 mg (n =127) | AOD9604 0.5 mg (n = 125) | AOD9604 1 mg (n =125) | Total (n =502) | |
---|---|---|---|---|---|
Any serious adverse event | 8 | 3 | 1 | 6 | 18 (3.6%) |